STORY AT-A-GLANCE
The latest SARS-CoV-2 variant, JN.1, was first detected in the U.S. in September 2023. By mid-December, it accounted for about half of all C***D cases in the country
According to the U.S. Centers for Disease Control and Prevention, the rapid spread of JN.1 suggests it may be more t***smissible and/or has greater immune-evading abilities
A vaccinology concept called “immune refocusing” explains how more dangerous v***ses can be created by leaky v*****es that do not prevent infection
By continuing with boosters, we accelerate immune escape. Over time, variants will get better and better at evading our immune responses, and those who keep taking boosters will be the most vulnerable to infection of all
Because of the mutations seen in JN.1, vaccinologist Geert Vanden Bossche, Ph.D., predicts we will “very soon” see variants that are more virulent but less infectious. If this happens, healthy unjabbed individuals are unlikely to be affected because their first line of defense — their innate i****e s****m — still works as it should. The jabbed, on the other hand, whose innate i****e s****ms have not been trained, and whose adaptive i****e s****ms have become increasingly useless, will be at very high risk of severe complications and death.
https://articles.mercola.com/sites/articles/archive/2024/01/09/jn1-c***d-variant.aspx?ui=44ca8b950287fe0b175cf0a970b6e0813b881d650372151b5f76d85067df491c&sd=20210822&cid_source=dnl&cid_medium=email&cid_content=art1ReadMore&cid=20240109_HL2&foDate=false&mid=DM1514519&rid=2014453143
If you want to reply, then
register here. Registration is free and your account is created instantly, so you can post right away.